Epstein-Barr virus (EBV) is a ubiquitous, oncogenic virus that is associated with a number of
different human malignancies as well as autoimmune disorders. The expression of EBV viral …

The complement system is deeply embedded in our physiology and immunity. Complement
activation generates a multitude of molecules that converge simultaneously on the …

Persistent infection by EBV is explained by the germinal center model (GCM) which provides
a satisfying and currently the only explanation for EBVs disparate biology. Since the GCM …

From the reviews of the 3rd Edition..." The standard reference for anyone interested in
understanding flow cytometry technology." American Journal of Clinical Oncology"... one of …

Acquired immune deficiency syndrome (AIDS) is characterized by opportunistic infections
and by 'opportunistic neoplasms'(for example, Kaposi's sarcoma) 1. Persistent generalized …

The Epstein–Barr virus (EBV) was discovered 36 years ago by electron microscopy of cells
cultured from Burkitt's lymphoma tissue by Epstein, Achong, and Barr. 1 Four years later, in …

The cell imposes multiple barriers to virus entry. However, viruses exploit fundamental
cellular processes to gain entry to cells and deliver their genetic cargo. Virus entry pathways …

Many viruses, including retroviruses, are characterized by their specific cell tropism1–3.
Lymphadenopathy-associated virus (LAV) is a human lymphotropic retrovirus isolated from …

Epstein-Barr virus (EBV) represents a major global health problem. Though it is associated
with infectious mononucleosis and∼ 200,000 cancers annually worldwide, a vaccine is not …

Restriction of poliovirus replication to a few sites in the infected primate host appears to be
controlled by the expression of viral receptors. To learn more about these binding sites and …